GHRH analogue whose identity and variant must be confirmed.
CJC-1295 is a GHRH analogue peptide. Commercial names involving DAC, no DAC, or similar terms should not be treated as describing the same formulation.
Research investigates GHRH signaling and changes in GH and IGF-1. Identifying the molecule and variant studied is essential.
The studied variant and its characteristics matter: findings cannot automatically transfer to every vial labeled CJC.
Before interpreting a page, confirm the exact compound, formulation, and presentation. For personal decisions, consult a healthcare professional; this information does not establish a dose or indication for you.
Yes. Formulation identity must be confirmed before interpreting studies or product information.
No. They describe an amount of substance, not the amount suitable for a person.
Check compound identity, formulation, route, studied population, and the original study. Seek qualified advice for personal decisions.
Online customer service and shipping throughout Costa Rica.
tribiopeptidoscr@gmail.com